Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04540029
Other study ID # MOM-COPE
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 6, 2020
Est. completion date May 15, 2024

Study information

Verified date May 2024
Source IRCCS National Neurological Institute "C. Mondino" Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The rapidly spreading coronavirus Covid-19 pandemic is a major concern worldwide and Italy is at the forefront of this emergency. At the present moment, the effects on the offspring of Covid-19 disease in pregnant women and/or the indirect effect of COVID-19-related prenatal maternal stress are poorly understood. Epigenetic mechanisms - and especially DNA methylation - are involved in the embedding of prenatal exposures to large-scale disasters into the epigenome and phenotypic outcomes of the offspring. Specific target genes include SLC6A4, NR3C1, OXTR, BDNF, and FKBP5. The central hypothesis of this project is that the exposure to the COVID-19-related prenatal maternal stress may affect infants' outcomes from birth to 12 months partially through increased methylation of target genes involved in stress regulation. The main goal is to investigate the association between Covid-19 disease in pregnancy or COVID-19-related PMS in women pregnant during the first 9 months of the year 2020 and the emotional, social, and cognitive developmental outcomes in their infants from birth to 12 months. Additionally, the role of target genes methylation in mediating this association will be investigated. Mothers and their infants will be enrolled from the delivery units of eleven neonatal facilities located in Northern Italy's COVID-19 contagion hotspot. One group will be enrolled from April to October 2020 (COVID-Exposure Pregnancy, CEP), a second group will be enrolled from April to October 2021 (Non-Exposure Pregnancy, NEP). Moreover, the CEP group will include mothers positive or exposed to COVID-19-related MPS during different trimesters of pregnancy, allowing within-group comparisons on developmentally sensitive time windows. Within 48 hours from baby delivery, saliva samples will be obtained from CEP and NEP newborns, immediately stored at -20°C and analyzed for epigenetic analyses using Next-Generation Sequencing. At 3 and 6 months, mothers will be asked to fill-in validated and reliable questionnaires on the emotional and social-behavioral development of their infants. At 12 months, infants' stress regulation and maternal sensitivity will be evaluated through video recording of mother-infant interactions. This study will provide unprecedented relevant insights on the biochemical mechanisms underlying the impact of Covid-19 disease and the related PMS on human offspring's developmental outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 350
Est. completion date May 15, 2024
Est. primary completion date April 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 0 Months to 12 Months
Eligibility Inclusion Criteria: - Italian nationality or full mastery of Italian language to access on-line questionnaires without support - No prenatal pathologies or perinatal risks - Maternal age higher than 18 years - Newborns' gestational age equal or higher than 37 weeks Exclusion Criteria: - Single-parent mothers - Medically assisted conception - Infants' genetic or metabolic comorbidities - Perinatal injuries or sensorial deficits

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Maternal stress
Prenatal COVID-19-related stress retrospectively self-reported by mothers after delivery.

Locations

Country Name City State
Italy IRCCS Mondino Foundation Pavia PV

Sponsors (1)

Lead Sponsor Collaborator
IRCCS National Neurological Institute "C. Mondino" Foundation

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Other Maternal target gene methylation status Methylation status of the following target genes: BDNF, FKBP5, NR3C1, OXTR, SLC6A4 At delivery
Other Maternal mental health Measure of maternal mental health obtained through the State dimension of the Stait-Trait Anxiety Inventory. The score ranges from 20 to 80, with a clinical cut-off set at 40. Higher scores reflect higher anxiety. At 3, 6, and 12 months of infants' age
Other Maternal sensitivity Maternal sensitivity measured by behavioral codings of mother-infant videorecorded interactions At 12 months of infants' age
Primary Infant negative emotionality Measure of infant Negative Emotionality through the Infant Behavior Questionnaire - Revised questionnaire. Negative Emotionality mean score ranges from 1 to 7 and higher scores reflect higher negative emotionality. At 12 months of infants' age
Secondary Infants' target gene methylation status Methylation status of the following target genes: BDNF, FKBP5, NR3C1, OXTR, SLC6A4 At birth
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05419167 - STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic Phase 1
Active, not recruiting NCT04713150 - HEALthy Brain and Child Development Study - COVID-19 Supplement
Completed NCT04100577 - Today Not Tomorrow Pregnancy and Infant Support Program (TNT- PISP) N/A
Recruiting NCT04154423 - Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study N/A
Recruiting NCT04993742 - Effects of Pregnancy-Specific Anxiety on Placental Inflammatory and Oxidative Stress Response and Birth Outcomes N/A
Suspended NCT05087329 - Mindfulness Practice in Pregnancy as an Intervention to Decrease Prenatal Stress During the COVID-19 Pandemic N/A
Completed NCT05824208 - PRENAYOGA: Exploratory Feasibility Study of Bi-weekly Pregnancy Yoga-based Sessions for Ethnic Minority Women N/A
Terminated NCT03809572 - Mindfulness Based Cognitive Therapy (MBCT) During Pregnancy N/A
Active, not recruiting NCT04718220 - Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19 N/A
Completed NCT03809598 - Roo Study on Mom and Baby Well-Being N/A
Completed NCT04293380 - Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome N/A
Completed NCT04267211 - Prenatal Consult With Illustrated Literature N/A
Active, not recruiting NCT04829864 - Supporting the Transition to and Engagement in Parenthood Phase 1/Phase 2
Active, not recruiting NCT03028857 - Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal Phase 1
Recruiting NCT03404141 - Stress Reduction Therapy for Pregnant Women N/A
Completed NCT03615261 - Wellness For 2: A Feasibility and Acceptability Pilot N/A
Completed NCT04427410 - The Relationship Between Oxytocin Level and Postpartum Depression
Active, not recruiting NCT05052281 - Promoting Healthy Brain Development: Wellness for 2 Study N/A
Not yet recruiting NCT05745896 - A Telemedicine Prenatal Care Model on Low Risk Pregnants: The m@Mae-e Study N/A
Recruiting NCT03970057 - MoodUP in Improving Psychological Outcomes Among Perinatal Women N/A